VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News

ETF Overview

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Key Stats

• Today's Range: $85.80 to $86.59
• 50-Day Range: $80.28 to $93.48
• 52-Week Range: $77.67 to $99.51
• Volume: 85,783 shs
• Average Volume: 235,852 shs
• Market Capitalization: $621.30 million
• Assets Under Management: $597.39 million
• Dividend Yield: 1.97%
• Net Expense Ratio: 0.36%
• Aggregate Rating: Moderate Buy

PPH ETF - Frequently Asked Questions

How have PPH shares performed this year?

VanEck Pharmaceutical ETF's stock was trading at $86.28 at the beginning of the year. Since then, PPH shares have increased by 0.2% and is now trading at $86.4110.
View the best growth stocks for 2025 here.

Who are VanEck Pharmaceutical ETF's major shareholders?

VanEck Pharmaceutical ETF's top institutional investors include Goldman Sachs Group Inc. (16.14%), Avalon Trust Co (3.95%), J.Safra Asset Management Corp (3.59%) and Miller Investment Management LP (2.64%).

How do I buy shares of VanEck Pharmaceutical ETF?

Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of VanEck Pharmaceutical ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Pharmaceutical ETF investors own include Waste Connections (WCN), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

• Issuer: Van Eck
• Fund Name: VanEck Pharmaceutical ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:PPH
• Inception Date: 12/20/2011
• Fund Manager: Hao-Hung Peter Liao, Guo Hua Jason Jin
• Web: N/A
• Phone: 14089961010

Fund Focus

• Asset Class: Equity
• Benchmark: Market Vectors US Listed Pharmaceutical 25 Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: Global
• Number of Holdings: 25

Fund Statistics

• Assets Under Management: $597.39 million
• Average Daily Volume: $504,337.60
• Discount/Premium: 0.00%

Administrator, Advisor and Custodian

• Administrator: Van Eck Associates Corporation
• Advisor: Van Eck Associates Corporation
• Custodian: State Street Bank and Trust Company
• Distributor: Van Eck Securities Corporation
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: IMC

Options

• Optionable: Optionable
• Options Volume: 1,181
• Put Options: 486
• Call Options: 695
• Short Interest: 2,570,000 shs

Miscellaneous

• Outstanding Shares: 7,190,000
• Beta: 0.72
• Creation Unit: 50,000
• Creation Fee: $500.00